$7.26
Live
Revenue is down for the last 3 quarters, 196.32M → 66.76M (in $), with an average decrease of 35.9% per quarter
Netprofit is down for the last 3 quarters, 12.57M → -23.50M (in $), with an average decrease of 138.2% per quarter
In the last 3 years, Arthur J Gallagher & Co. has given 120.3% return, outperforming this stock by 210.6%
0.0%
Downside
Day's Volatility :2.42%
Upside
2.42%
63.22%
Downside
52 Weeks Volatility :74.74%
Upside
31.32%
Period | Ehealth Inc | Sector (Financials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -6.34% | 0.2% | 0.0% |
6 Months | -19.32% | 5.1% | -0.1% |
1 Year | 84.75% | 9.3% | 5.6% |
3 Years | -90.29% | 41.0% | 17.6% |
Market Capitalization | 208.1M |
Book Value | $21.47 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -3.35 |
PEG Ratio | 0.72 |
Wall Street Target Price | 11.33 |
Profit Margin | -15.85% |
Operating Margin TTM | -13.62% |
Return On Assets TTM | -3.09% |
Return On Equity TTM | -6.86% |
Revenue TTM | 390.2M |
Revenue Per Share TTM | 14.15 |
Quarterly Revenue Growth YOY | 32.5% |
Gross Profit TTM | 403.7M |
EBITDA | -50.0M |
Diluted Eps TTM | -3.35 |
Quarterly Earnings Growth YOY | -0.39 |
EPS Estimate Current Year | -0.62 |
EPS Estimate Next Year | -0.47 |
EPS Estimate Current Quarter | -1.11 |
EPS Estimate Next Quarter | -1.25 |
What analysts predicted
Upside of 56.06%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 172.4M | ↓ 7.81% |
Net Income | -25.4M | ↑ 420.52% |
Net Profit Margin | -14.74% | ↓ 12.13% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 251.4M | ↑ 45.86% |
Net Income | 241.0K | ↓ 100.95% |
Net Profit Margin | 0.1% | ↑ 14.84% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 506.2M | ↑ 101.36% |
Net Income | 66.9M | ↑ 27653.94% |
Net Profit Margin | 13.21% | ↑ 13.11% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 582.8M | ↑ 15.13% |
Net Income | 45.5M | ↓ 32.05% |
Net Profit Margin | 7.8% | ↓ 5.41% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 538.2M | ↓ 7.65% |
Net Income | -104.4M | ↓ 329.65% |
Net Profit Margin | -19.39% | ↓ 27.19% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 405.4M | ↓ 24.68% |
Net Income | -119.4M | ↑ 14.41% |
Net Profit Margin | -29.46% | ↓ 10.07% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 105.3M | ↓ 56.78% |
Net Income | -32.7M | ↑ 1.84% |
Net Profit Margin | -31.11% | ↓ 17.91% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 50.4M | ↓ 52.11% |
Net Income | -37.5M | ↑ 14.54% |
Net Profit Margin | -74.4% | ↓ 43.29% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 53.4M | ↑ 5.89% |
Net Income | -39.1M | ↑ 4.39% |
Net Profit Margin | -73.35% | ↑ 1.05% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 196.3M | ↑ 267.81% |
Net Income | 12.6M | ↓ 132.11% |
Net Profit Margin | 6.4% | ↑ 79.75% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 73.7M | ↓ 62.45% |
Net Income | -19.9M | ↓ 258.11% |
Net Profit Margin | -26.96% | ↓ 33.36% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 66.8M | ↓ 9.43% |
Net Income | -23.5M | ↑ 18.23% |
Net Profit Margin | -35.2% | ↓ 8.24% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 88.7M | ↓ 18.56% |
Total Liabilities | 27.5M | ↓ 11.98% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 439.3M | ↑ 395.3% |
Total Liabilities | 136.1M | ↑ 394.17% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 741.6M | ↑ 68.83% |
Total Liabilities | 214.5M | ↑ 57.55% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.0B | ↑ 40.23% |
Total Liabilities | 202.5M | ↓ 5.6% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 10.51% |
Total Liabilities | 167.2M | ↓ 17.43% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↓ 3.19% |
Total Liabilities | 198.4M | ↑ 18.66% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.2B | ↑ 1.18% |
Total Liabilities | 207.1M | ↑ 23.89% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↓ 5.84% |
Total Liabilities | 172.0M | ↓ 16.96% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↓ 3.93% |
Total Liabilities | 163.2M | ↓ 5.11% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↑ 5.77% |
Total Liabilities | 198.4M | ↑ 21.54% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↓ 2.66% |
Total Liabilities | 183.7M | ↓ 7.41% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↓ 2.73% |
Total Liabilities | 172.5M | ↓ 6.07% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -15.5M | ↓ 480.63% |
Investing Cash Flow | -5.1M | ↑ 36.29% |
Financing Cash Flow | -870.0K | ↓ 31.44% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.2M | ↓ 79.22% |
Investing Cash Flow | -25.8M | ↑ 407.23% |
Financing Cash Flow | 1.9M | ↓ 313.79% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -71.5M | ↑ 2113.37% |
Investing Cash Flow | -16.9M | ↓ 34.22% |
Financing Cash Flow | 102.1M | ↑ 5391.45% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -107.9M | ↑ 50.87% |
Investing Cash Flow | -73.3M | ↑ 332.5% |
Financing Cash Flow | 201.2M | ↑ 97.03% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -162.6M | ↑ 50.77% |
Investing Cash Flow | -12.6M | ↓ 82.76% |
Financing Cash Flow | 213.2M | ↑ 5.96% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -26.9M | ↓ 83.48% |
Investing Cash Flow | 25.9M | ↓ 304.74% |
Financing Cash Flow | 63.8M | ↓ 70.06% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 47.1M | ↓ 146.05% |
Investing Cash Flow | 26.1M | ↑ 7.98% |
Financing Cash Flow | 65.4M | ↑ 2709.33% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -25.8M | ↓ 154.69% |
Investing Cash Flow | 2.1M | ↓ 91.8% |
Financing Cash Flow | -2.0M | ↓ 102.99% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -29.6M | ↑ 15.02% |
Investing Cash Flow | -4.1M | ↓ 292.67% |
Financing Cash Flow | -493.0K | ↓ 74.78% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -18.6M | ↓ 37.31% |
Investing Cash Flow | 1.7M | ↓ 141.8% |
Financing Cash Flow | 913.0K | ↓ 285.19% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 60.8M | ↓ 427.27% |
Investing Cash Flow | -24.2M | ↓ 1504.4% |
Financing Cash Flow | -439.0K | ↓ 148.08% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -9.4M | ↓ 115.51% |
Investing Cash Flow | -16.5M | ↓ 31.78% |
Financing Cash Flow | -1.2M | ↑ 184.28% |
Sell
Neutral
Buy
Ehealth Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Ehealth Inc | -7.63% | -19.32% | 84.75% | -90.29% | -74.35% |
![]() Willis Towers Watson Plc | 2.05% | -8.04% | 4.75% | 1.82% | 49.47% |
![]() Marsh & Mclennan Companies, Inc. | -1.63% | 17.58% | 28.38% | 69.57% | 131.84% |
![]() Arthur J Gallagher & Co. | -0.01% | 22.1% | 34.84% | 120.26% | 207.0% |
![]() Aon Plc | -1.15% | 5.34% | 21.56% | 60.6% | 112.71% |
![]() Brown & Brown Inc. | -3.87% | 25.61% | 16.39% | 56.9% | 140.24% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Ehealth Inc | NA | NA | 0.72 | -0.62 | -0.07 | -0.03 | 0.0 | 21.47 |
![]() Willis Towers Watson Plc | 21.23 | 21.23 | 0.75 | 13.83 | 0.11 | 0.04 | 0.02 | 93.37 |
![]() Marsh & Mclennan Companies, Inc. | 29.39 | 29.39 | 3.41 | 7.74 | 0.29 | 0.08 | 0.01 | 24.21 |
![]() Arthur J Gallagher & Co. | 44.9 | 44.9 | 2.09 | 8.76 | 0.12 | 0.03 | 0.01 | 48.24 |
![]() Aon Plc | 25.65 | 25.65 | 1.77 | 14.2 | 0.58 | 0.07 | 0.01 | 0.32 |
![]() Brown & Brown Inc. | 27.5 | 27.5 | 4.41 | 2.65 | 0.16 | 0.05 | 0.01 | 17.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Ehealth Inc | Buy | $208.1M | -74.35% | NA | -15.85% |
![]() Willis Towers Watson Plc | Hold | $21.8B | 49.47% | 21.23 | 11.84% |
![]() Marsh & Mclennan Companies, Inc. | Hold | $95.5B | 131.84% | 29.39 | 15.2% |
![]() Arthur J Gallagher & Co. | Buy | $49.6B | 207.0% | 44.9 | 12.59% |
![]() Aon Plc | Hold | $66.9B | 112.71% | 25.65 | 20.78% |
![]() Brown & Brown Inc. | Buy | $20.1B | 140.24% | 27.5 | 18.45% |
Palo Alto Investors, LLC
BlackRock Inc
Vanguard Group Inc
G2 Investment Partners Management LLC
Nantahala Capital Management, LLC
Dimensional Fund Advisors, Inc.
Ehealth Inc’s price-to-earnings ratio stands at None
Read Moreehealth, inc. (nasdaq: ehth) operates ehealthinsurance.com, the nation’s first and largest private health insurance exchange where individuals, families and small businesses can compare health insurance products from leading insurers side by side and purchase and enroll in coverage online. ehealthinsurance offers thousands of individual, family and small business health plans underwritten by more than 200 of the nation's leading health insurance companies. ehealthinsurance is licensed to sell health insurance in all 50 states and the district of columbia. ehealth, inc. also provides powerful online and pharmacy-based tools to help medicare beneficiaries navigate medicare health insurance options, choose the right plan and enroll in select plans online through planprescriber.com (www.planprescriber.com) and ehealthmedicare.com (www.ehealthmedicare.com). for more health insurance news and information, visit the ehealth consumer blog: get smart – get covered or visit ehealth’s affordable
Organization | Ehealth Inc |
Employees | 1515 |
CEO | Mr. Francis Samuel Soistman Jr. |
Industry | Finance |
Innovator S&p 500 Power-jan
$7.26
-1.76%
Energy Fuels Inc/canada
$7.26
-1.76%
Cohen & Steers Closed-end Op
$7.26
-1.76%
Despegar.com Corp
$7.26
-1.76%
Sonder Holdings Inc
$7.26
-1.76%
Flexshares Quality Dividend
$7.26
-1.76%
Star Group Lp
$7.26
-1.76%
Gamco Global Gold Natural Resources & Income Trust
$7.26
-1.76%
Radnet Inc
$7.26
-1.76%